An epidemic of lymphogranuloma venereum among men who have sex with men (MSM) has persisted in Australia for over a decade and virtually all diagnoses are made from rectal samples. We discuss two cases of human immunodeficiency virus-negative MSM who presented with a penile ulcer. The diagnosis can be made by ensuring a swab of any such ulcer is tested for Chlamydia trachomatis.
TempletonDJResslerK-AHopeKet al.
Enhanced surveillance of a lymphogranuloma venereum outbreak in Sydney 2010–2012. Aust NZ J Public Health2016;
40: 368–370.
3.
De VriezeNVan RooijenMVan der LoeffMet al.
Anorectal and inguinal lymphogranuloma venereum among men who have sex with men in Amsterdam, the Netherlands: trends over time, symptomatology and concurrent infections. Sex Transm Infect2013;
89: 548–552.
4.
ReadPMcNultyA.Lymphogranuloma venereum presenting as genital ulcer and inguinal adenopathy syndrome. Med J Aust2013;
199: 27–28.
SethiGAllason-JonesERichensJet al.
Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome in men who have sex with men in London, United Kingdom. Sex Transm Infect2009;
85: 165–170.
8.
WhiteJ.Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis2009;
22: 57–66.
9.
De VriesHJC.The enigma of lymphogranuloma venereum spread in men who have sex with men: does ano-oral transmission plays a role?.Sex Transm Dis2016;
43: 420–422.
10.
De VriezeNHNVersteegBBruistenSMet al.
Low prevalence of urethral lymphogranuloma venereum infections among men who have sex with men: a prospective observational study, Sexually Transmitted Infection Clinic in Amsterdam, the Netherlands. Sex Transm Dis2017;
44: 547–550.
11.
DosekunOEdmondsSStockwellSet al.
Pharyngeal lymphogranuloma venereum: four cases in men who have sex with men. Sex Transm Infect2012;
88: A9.
12.
MayerKHBeyrerC.Antiretroviral chemoprophylaxis: PROUD and pragmatism. Lancet2016;
387: 6–7.
13.
McCormackSDunnDTDesaiDet al.
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet2016;
387: 53–60.
14.
NguyenVKGreenwaldZRTrottierHet al.
Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS2018;
32: 523530.
15.
GolubSAPenaSFikslinRAet al. Partners, not condom use, drive STI rates among prep users in community health center. In: Conference on retroviruses and opportunistic infections, Boston, March 2018, paper no. 1025.
16.
HoornenborgECoyerLNAchterberghRCet al. Incident HIV, hepatitis C and other STI in daily and event-driven PrEP users. In: Conference on retroviruses and opportunistic infections, Boston, March 2018, paper no. 1026.
17.
KojimaNDaveyDJKlausnerJD.Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men. AIDS2016;
30: 2251–2252.
18.
TraegerMWSchroederSEWrightEJet al.Effects of pre-exposure prophylaxis for the prevention of HIV infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis 2018; 67: 676–686. doi: 10.1093/cid/ciy182.
19.
Public Health England. Recent trends in lymphogranuloma venereum (LGV) diagnoses in the United Kingdom: 2003–2016. Health Protection Report, Vol. 11(37), 20 October 2017.
20.
Australasian Society for HIV, Viral hepatitis and sexual health medicine. Australian STI management guidelines for use in primary care. 2017/18 annual critical review, www.sti.guidelines.org.au (accessed 2 November 2018).
21.
ShieldsMGuyRJJeoffreysNJet al.
A longitudinal evaluation of Treponema pallidum PCR testing in early syphilis. BMC Infect Dis2012;
12: 353–358.
22.
MensforthSRadcliffeK.Is it time to reconsider epidemiological treatment for gonorrhoea?Int J STD AIDS2018;
29: 1043–1044.
23.
PearceEChanDJSmithDE.Empiric antimicrobial treatment for asymptomatic sexual contacts of sexually transmitted infection in the era of antimicrobial resistance: time to rethink?Int J STD AIDS2018. Epub ahead of print. doi: 10.1177/0956462418799181.
24.
TurnerKMERoundJHornerPet al.
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. Sex Transm Infect2014;
90: 104–111.
25.
TabriziSNUnemoMGolparianDet al.; on behalf of the TTANGO Investigators.
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol2013;
51: 1945–1947.
